Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Melén CM"'
Autor:
Melén CM; Unit of Hematology, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Merrien M; Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Wasik AM; Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Sander B; Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Pathology, Karolinska University Hospital, Stockholm, Sweden., Wahlin BE; Unit of Hematology, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Panagiotis G; Department of Clinical Pharmacology, University Hospital, Stockholm, Sweden.; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Beck O; Department of Clinical Pharmacology, University Hospital, Stockholm, Sweden.; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
Cannabis and cannabinoid research [Cannabis Cannabinoid Res] 2024 Jun; Vol. 9 (3), pp. e839-e846. Date of Electronic Publication: 2023 Apr 19.
Autor:
Merrien M; Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden., Wasik AM; Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden., Melén CM; Division of Haematology, Department of Medicine at Huddinge, Karolinska Institutet, 171 77 Stockholm, Sweden.; Unit of Haematology, Karolinska University Hospital, 171 76 Stockholm, Sweden., Morsy MHA; Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden., Sonnevi K; Division of Haematology, Department of Medicine at Huddinge, Karolinska Institutet, 171 77 Stockholm, Sweden.; Unit of Haematology, Karolinska University Hospital, 171 76 Stockholm, Sweden., Junlén HR; Division of Haematology, Department of Medicine at Huddinge, Karolinska Institutet, 171 77 Stockholm, Sweden.; Unit of Haematology, Karolinska University Hospital, 171 76 Stockholm, Sweden., Christensson B; Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.; Pathology and Cancer, Karolinska University Hospital, 141 86 Stockholm, Sweden., Wahlin BE; Division of Haematology, Department of Medicine at Huddinge, Karolinska Institutet, 171 77 Stockholm, Sweden.; Unit of Haematology, Karolinska University Hospital, 171 76 Stockholm, Sweden., Sander B; Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.; Pathology and Cancer, Karolinska University Hospital, 141 86 Stockholm, Sweden.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Mar 03; Vol. 15 (5). Date of Electronic Publication: 2023 Mar 03.
Autor:
Melén CM; Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Hematology, Karolinska University Hospital, Stockholm, Sweden., Merrien M; Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden., Wasik AM; Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden., Panagiotidis G; Department of Laboratory Medicine, Division of Pharmacology, Karolinska Institutet, Stockholm, Sweden.; Unit of Clinical Pharmacology, University Hospital, Stockholm, Sweden., Beck O; Department of Laboratory Medicine, Division of Pharmacology, Karolinska Institutet, Stockholm, Sweden.; Unit of Clinical Pharmacology, University Hospital, Stockholm, Sweden., Sonnevi K; Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Hematology, Karolinska University Hospital, Stockholm, Sweden., Junlén HR; Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Hematology, Karolinska University Hospital, Stockholm, Sweden., Christensson B; Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden., Sander B; Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden., Wahlin BE; Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Hematology, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Jun; Vol. 63 (6), pp. 1387-1397. Date of Electronic Publication: 2022 Jan 17.
Autor:
Sonnevi K; Division of Haematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.; Hematology Dept, Karolinska University Hospital, Stockholm, Sweden., Wästerlid T; Hematology Dept, Karolinska University Hospital, Stockholm, Sweden.; Unit of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Melén CM; Division of Haematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.; Hematology Dept, Karolinska University Hospital, Stockholm, Sweden., Harrysson S; Hematology Dept, Karolinska University Hospital, Stockholm, Sweden.; Unit of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Smedby KE; Hematology Dept, Karolinska University Hospital, Stockholm, Sweden.; Unit of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Wahlin BE; Division of Haematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.; Hematology Dept, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
British journal of haematology [Br J Haematol] 2021 Jan; Vol. 192 (1), pp. 75-81. Date of Electronic Publication: 2020 May 12.
Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma.
Autor:
Enqvist M; Department of Medicine, Center for Infectious Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden., Jacobs B; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany., Junlén HR; Division of Hematology, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.; Center for Hematology, Karolinska University Hospital, Stockholm, Sweden., Schaffer M; Department of Medicine, Center for Infectious Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden., Melén CM; Center for Hematology, Karolinska University Hospital, Stockholm, Sweden.; Department of Oto-Rhino-Laryngology, Karolinska University Hospital and CLINTEC, Karolinska Institutet, Stockholm, Sweden., Friberg D; Department of Oto-Rhino-Laryngology, Karolinska University Hospital and CLINTEC, Karolinska Institutet, Stockholm, Sweden., Wahlin BE; Division of Hematology, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.; Center for Hematology, Karolinska University Hospital, Stockholm, Sweden., Malmberg KJ; Department of Medicine, Center for Infectious Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Division of Hematology, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.; Center for Hematology, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
Frontiers in immunology [Front Immunol] 2019 Sep 12; Vol. 10, pp. 2085. Date of Electronic Publication: 2019 Sep 12 (Print Publication: 2019).
Autor:
Carlsten M; 1Center for Hematology and Regenerative Medicine, Dept. of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.; 2PO Hematology, Karolinska University Hospital, Stockholm, Sweden., Jädersten M; 1Center for Hematology and Regenerative Medicine, Dept. of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.; 2PO Hematology, Karolinska University Hospital, Stockholm, Sweden., Hellström A; 1Center for Hematology and Regenerative Medicine, Dept. of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.; 2PO Hematology, Karolinska University Hospital, Stockholm, Sweden., Littmann K; 3Division of Clinical Chemistry, Dept. of Laboratory Medicine, H5, Karolinska Institutet, Stockholm, Sweden., Melén CM; 2PO Hematology, Karolinska University Hospital, Stockholm, Sweden.; 4Division of Hematology, Dept. of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden., Junlén HR; 2PO Hematology, Karolinska University Hospital, Stockholm, Sweden.; 4Division of Hematology, Dept. of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden., Sonnevi K; 2PO Hematology, Karolinska University Hospital, Stockholm, Sweden.; 4Division of Hematology, Dept. of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden., Ljungman P; 4Division of Hematology, Dept. of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.; 5Dept. of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden., Björkstrand B; 2PO Hematology, Karolinska University Hospital, Stockholm, Sweden.; 4Division of Hematology, Dept. of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden., Wahlin BE; 2PO Hematology, Karolinska University Hospital, Stockholm, Sweden.; 4Division of Hematology, Dept. of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
Experimental hematology & oncology [Exp Hematol Oncol] 2019 Mar 18; Vol. 8, pp. 7. Date of Electronic Publication: 2019 Mar 18 (Print Publication: 2019).
Autor:
Melén CM; Division of Haematology, Department of Medicine, Huddinge, Sweden.; Karolinska Institutet, and Haematology Centre, Karolinska University Hospital, Stockholm, Sweden., Enblad G; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden., Sonnevi K; Division of Haematology, Department of Medicine, Huddinge, Sweden.; Karolinska Institutet, and Haematology Centre, Karolinska University Hospital, Stockholm, Sweden., Junlén HR; Division of Haematology, Department of Medicine, Huddinge, Sweden.; Karolinska Institutet, and Haematology Centre, Karolinska University Hospital, Stockholm, Sweden., Smedby KE; Unit of Clinical Epidemiology, Department of Medicine, Solna, Sweden., Jerkeman M; Department of Oncology, Lund University Hospital, Lund, Sweden., Wahlin BE; Division of Haematology, Department of Medicine, Huddinge, Sweden.; Karolinska Institutet, and Haematology Centre, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
British journal of haematology [Br J Haematol] 2016 Nov; Vol. 175 (4), pp. 614-622. Date of Electronic Publication: 2016 Oct 28.